Profile data is unavailable for this security.
About the company
DaShenLin Pharmaceutical Group Co Ltd is a China-based company principally engaged in the pharmaceutical retailing business. The Company's primary business includes direct sales and retailing of Chinese and Western medicine, ginseng nourishing herbs and Chinese medicine pieces, health products, medical apparatus and instruments and other commodities. The Company mainly conducts its business within domestic market.
- Revenue in CNY (TTM)26.54bn
- Net income in CNY850.26m
- Incorporated1999
- Employees45.47k
- LocationDaShenLin Pharmaceutical Group Co LtdNo. 410410-1, Longxi Avenue, Liwan DistrictGUANGZHOU 510000ChinaCHN
- Phone+86 2 081689688
- Fax+86 2 081176091
- Websitehttp://www.dslyy.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| JZJ Chain Drugstore Corp | 9.32bn | 236.80m | 4.02bn | 16.65k | 16.73 | 1.45 | -- | 0.4312 | 1.53 | 1.53 | 60.20 | 17.72 | 0.9258 | 2.20 | 20.72 | 559,572.20 | 2.34 | 5.75 | 4.50 | 11.17 | 35.54 | 35.21 | 2.53 | 5.04 | 0.2655 | 2.88 | 0.6563 | 36.62 | 20.84 | 26.84 | 10.72 | 25.41 | 23.62 | -- |
| Genky DrugStores Co Ltd | 8.77bn | 301.64m | 4.39bn | 1.66k | 14.29 | 1.92 | 7.73 | 0.5003 | 212.46 | 212.46 | 6,180.37 | 1,582.20 | 1.67 | 6.47 | 43.31 | 113,208,300.00 | 5.76 | 4.94 | 8.65 | 7.86 | 20.41 | 20.67 | 3.44 | 2.98 | 0.4102 | 59.82 | 0.4195 | 8.24 | 9.35 | 12.21 | 32.75 | 18.58 | -0.5316 | 0.3968 |
| MedPlus Health Services Ltd | 4.92bn | 64.17m | 6.76bn | 21.00k | 105.78 | -- | 26.00 | 1.37 | 6.34 | 6.34 | 485.51 | -- | -- | -- | -- | 2,775,897.00 | -- | 2.68 | -- | 3.48 | 22.11 | 21.14 | 1.31 | 1.38 | -- | 1.48 | -- | 0.00 | 23.42 | 19.87 | 31.57 | 40.59 | 31.14 | -- |
| Fangzhou Inc | 2.46bn | -859.46m | 9.01bn | 515.00 | -- | -- | -- | 3.66 | -0.702 | -0.702 | 2.01 | -1.62 | -- | -- | -- | 5,229,344.00 | -- | -- | -- | -- | 20.52 | -- | -34.94 | -- | 0.699 | -- | 30.75 | -- | 10.43 | -- | 48.66 | -- | -- | -- |
| Welcia Holdings Co Ltd | 57.72bn | 1.02bn | 18.35bn | 15.29k | 17.68 | 1.57 | 8.55 | 0.3179 | 106.05 | 106.05 | 5,982.48 | 1,194.41 | 2.11 | 6.31 | 17.08 | 80,917,640.00 | 3.67 | 5.76 | 6.63 | 10.23 | 30.23 | 30.81 | 1.74 | 2.51 | 0.6511 | 38.94 | 0.2343 | 23.97 | 6.38 | 9.33 | -2.14 | 8.71 | 2.59 | 10.12 |
| Dashenlin Pharmaceutical Group Co Ltd | 26.54bn | 850.26m | 19.05bn | 45.47k | 22.47 | 2.77 | -- | 0.7179 | 0.7445 | 0.7445 | 23.37 | 6.03 | 1.12 | 4.14 | 23.28 | 583,716.30 | 3.90 | 6.57 | 8.15 | 12.63 | 33.80 | 37.51 | 3.47 | 5.54 | 0.598 | 7.15 | 0.5981 | 45.67 | 15.45 | 22.59 | 12.63 | 17.02 | 26.51 | 6.85 |
| Yifeng Pharmacy Chain Co Ltd | 23.92bn | 1.52bn | 31.40bn | 39.65k | 20.58 | 3.06 | -- | 1.31 | 1.26 | 1.26 | 19.77 | 8.46 | 0.9734 | 4.00 | 14.51 | 603,225.00 | 6.72 | 6.93 | 12.76 | 12.47 | 38.47 | 38.73 | 6.90 | 6.71 | 0.8771 | 34.97 | 0.5237 | 26.56 | 13.59 | 26.72 | 11.57 | 27.66 | 25.93 | 33.54 |
| MatsukiyoCocokara & Co | 48.25bn | 2.43bn | 40.28bn | 13.37k | 16.67 | 1.67 | 11.50 | 0.8347 | 124.58 | 124.58 | 2,476.56 | 1,241.32 | 1.47 | 4.73 | 17.89 | 77,335,880.00 | 7.43 | 6.80 | 9.59 | 8.87 | 34.73 | 33.45 | 5.06 | 4.57 | 1.31 | -- | 0.0362 | 28.65 | 7.49 | 12.16 | 29.11 | 15.90 | 29.38 | 11.10 |
| Alibaba Hlth Infrmtn Tchnlgy Ltd | 26.96bn | 881.26m | 58.79bn | 1.44k | 58.32 | 4.04 | 62.92 | 2.18 | 0.0686 | 0.0686 | 2.09 | 0.9892 | 1.34 | 12.07 | 39.74 | 20,567,430.00 | 4.37 | 1.89 | 5.88 | 2.54 | 21.81 | 21.67 | 3.27 | 1.49 | 2.41 | -- | 0.0056 | 0.00 | 0.9847 | 39.61 | 64.93 | -- | 30.14 | -- |
| JD Health International Inc | 54.63bn | 2.61bn | 80.00bn | 3.18k | 30.32 | 1.54 | 28.26 | 1.46 | 0.9052 | 0.9052 | 18.92 | 17.85 | 0.8519 | 7.84 | 157.40 | 19,180,360.00 | 4.07 | -8.61 | 5.16 | -10.70 | 22.57 | 22.76 | 4.78 | -10.39 | 3.35 | -- | 0.0042 | -- | 14.54 | 45.64 | 463.49 | 58.38 | 95.69 | -- |
Data as of Nov 05 2024. Currency figures normalised to DaShenLin Pharmaceutical Group Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
7.37%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| CITIC Securities Co., Ltd. (Invt Port)as of 30 Sep 2023 | 19.99m | 1.76% |
| FIL Investment Management (Hong Kong) Ltd.as of 30 Sep 2024 | 16.85m | 1.48% |
| Lazard Asset Management LLCas of 30 Sep 2024 | 14.24m | 1.25% |
| GF Fund Management Co., Ltd.as of 30 Jun 2024 | 6.39m | 0.56% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2024 | 6.31m | 0.56% |
| Cinda Fund Management Co. Ltd.as of 30 Jun 2024 | 5.39m | 0.47% |
| FIL Investment Management (Singapore) Ltd.as of 30 Sep 2024 | 5.29m | 0.47% |
| Zhong Ou Asset Management Co., Ltdas of 30 Jun 2024 | 3.41m | 0.30% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2024 | 3.30m | 0.29% |
| China International Capital Corp. HK Asset Management Ltd.as of 30 Jun 2024 | 2.64m | 0.23% |
More ▼
Data from 30 Jun 2024 - 29 Oct 2024Source: FactSet Research Systems Inc.
